Back to company

immunAware ApS: Financial statements 2020

CVR: 39189135

immunAware ApS (CVR 39189135) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,395,210 and a net result of DKK 1,211,357 compared with DKK 1,388,135 the year before. That is an increase of 4.9% compared with the year before. Equity amounted to DKK 2,590,727. The solvency ratio was 79.8%. The company had 1 employee in the financial year.

Gross Profit
2,395,210 kr.
Profit/Loss
1,211,357 kr.
Equity
2,590,727 kr.
Total Assets
3,246,748 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-2.4 mio.1.2 mio.2.6 mio.1
2019-2.3 mio.1.4 mio.1.5 mio.1
2018-25 t.19 t.151 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is immunAware ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

ImmunAware ApS: The 2019 annual report is outJun 11, 2020

ImmunAware ApS has published its annual report for 2019. Gross profit came to DKK 2,283,575, and the net result was DKK 1,388,135.

About immunAware ApS

immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity amounted to DKK 4,913,587.

Other financial years